AAAAAA

   
Results: 1-18 |
Results: 18
MORTALITY IN DATATOP - A MULTICENTER TRIAL IN EARLY PARKINSONS-DISEASE
Authors: SHOULSON I OAKES D FAHN S LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E GRAEFE K BURKE C MARCUS A DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY M SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K
Citation: I. Shoulson et al., MORTALITY IN DATATOP - A MULTICENTER TRIAL IN EARLY PARKINSONS-DISEASE, Annals of neurology, 43(3), 1998, pp. 318-325
THE NEED FOR LEVODOPA AS AN END-POINT OF PARKINSONS-DISEASE PROGRESSION IN A CLINICAL-TRIAL OF SELEGILINE AND ALPHA-TOCOPHEROL
Authors: LEWITT P OAKES D CUI L
Citation: P. Lewitt et al., THE NEED FOR LEVODOPA AS AN END-POINT OF PARKINSONS-DISEASE PROGRESSION IN A CLINICAL-TRIAL OF SELEGILINE AND ALPHA-TOCOPHEROL, Movement disorders, 12(2), 1997, pp. 183-189
ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS
Authors: KIEBURTZ K SHOULSON I FAHN S MCDERMOTT M KOLLER W LEWITT P NUTT J KURTH M BREWER M LEW M WELSH M WATERS C BENNETT J ROSTRUFFNER E FEIGIN A GARDINER I KURLAN R HAMMERSTAD J STONE C JANKOVIC J BEACH J TETRUD J KELKER K STANDAERT DG GROWDON JH TENNIS M GRAEFE K MARK MH KELLY SJ PAHWA R MCGUIRE D HUBBLE J FACTOR SA BROWN DL TUITE P SIME E LANG DL GREENE P WINFIELD H PAULSON G ZOOG K WEEKS C SHULTS C FONTAINE D JUNCOS JL WOOD C SHANNON K JAGLIN JA TORNABENE J LANNON MC DAVIES R FRIEDMAN J TARIOT PN HALL WJ HERNDON R PFEIFFER RF PLUMB S CASACELI C RANDOLPH H BEHMAN H CONNORTON J DAY D RUDOLPH A PELUSIO R GUTHRIE B CLAUDE K ORME C BAKER D NOBEL R IRVINE C WATTS A GORDIN A HEIKKINEN H RITA H
Citation: K. Kieburtz et al., ENTACAPONE IMPROVES MOTOR FLUCTUATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASE PATIENTS, Annals of neurology, 42(5), 1997, pp. 747-755
A 6-MONTH OPEN-LABEL TRIAL OF TOLCAPONE IN PARKINSONS-DISEASE
Authors: CHARLES PD DAVIS TL SAINTHILAIRE MH TROSCH RM LEWITT P KURTH MC PEDDER S DORFLINGER E
Citation: Pd. Charles et al., A 6-MONTH OPEN-LABEL TRIAL OF TOLCAPONE IN PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 64-64
TOLCAPONE IN STABLE PARKINSONS-DISEASE - EFFICACY AND SAFETY OF LONG-TERM TREATMENT
Authors: WATERS CH KURTH M BAILEY P SHULMAN LM LEWITT P DORFLINGER E DEPTULA D PEDDER S
Citation: Ch. Waters et al., TOLCAPONE IN STABLE PARKINSONS-DISEASE - EFFICACY AND SAFETY OF LONG-TERM TREATMENT, Neurology, 49(3), 1997, pp. 665-671
SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE
Authors: RICHARD IH KURLAN R TANNER C FACTOR S HUBBLE J SUCHOWERSKY O WATERS C GOETZ C JUNCOS JL STERN M HARRISON MB SETHI KD STANDAERT D TROSCH R REICH S KIEBURTZ K FEIGIN A MARSHALL FJ GAUTHIER S PANISSET M LEW ME FRIEDMAN JH PAULSON G RODNITZKY RL HAUSER R KURTH M HURTIG H THAL L ELMER LW PERLMUTTER JS GOLBE LI COMELLA C LANG A MARK MH SINGER C SHOULSON I WEINER WJ PFEIFFER R MAREK KL NUTT J WOOTEN GF JANKOVIC J LEWITT P HOEHN M BENNETT J PARSA M KOLLER W
Citation: Ih. Richard et al., SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE, Neurology, 48(4), 1997, pp. 1070-1077
TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Authors: KURTH MC ADLER CH STHILAIRE M SINGER C WATERS C LEWITT P CHERNIK DA DORFLINGER EE YOO K LIEBERMAN AN BREWER M SAINTHILAIRE M PERY LM THOMAS C TURPIN L OBRIEN CF SEEBERGER LC DUNCAN KL CAVINESS JN DOUGLAS M WHEELER K RILEY D RAINEY P TANNER CM KELKER K LEWIS P TROSCH RM MISTURA KL MONTGOMERY EB LINDSEY B WEINER W SHULMAN LM SHELDON C WATERS CH WELSH M TRUGMAN JM LANDOW ER PEDDER SCJ SHIMON GS MAGNI G
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Neurology, 48(1), 1997, pp. 81-87
COMPARISON OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PARKINSONS-DISEASE - A MULTICENTER 5-YEAR STUDY/
Authors: BLOCK G LISS C REINES S IRR J NIBBELINK D AARLI J AGUILAR M AHRENS S BAKHEIT A BAUMEL B BERTONI J CAPILDEO R CASTROCALDAS A DEZA L DONALDSON I FRANCK G FUSILLO J GAUTHIER S GERSHANIK O GRANERUS AK HAUSER RA HENNESSEY K HUTTON JT JOFFE R KOLLER W LAST B LEWITT P MAMOLI B MANYAM B MARK M NAKANO K NAUSIEDA P OTERO E PAULSON G PINTER M REICH S RODNITZKY R SAGE J SAMPAIO C SMITH B TERAVAINEN H TETRUD J TOLOSA E ULM G VALESCO F
Citation: G. Block et al., COMPARISON OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PARKINSONS-DISEASE - A MULTICENTER 5-YEAR STUDY/, European neurology, 37(1), 1997, pp. 23-27
EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I FAHN S BRIN M GOETZ C LANG A OLANOW CW LEWITT P MISTURA K WATERS C WELSH M RODNITZKY R DOBSON J ARGATOFF P TANNER C LEWIS P WATTS R BRYAN B COMELLA C JAGLIN JA SHULTS C FONTAINE D BRESSMAN SB MOSKOWITZ C HURTIG HI SHALLOW K HUBBLE J BARTER R BENNETT JP ROSTRUFFNER E PERLMUTTER JS MCGEEMINNICH L HAUSER R GAUGER L RAJPUT AH SUTTON A TRINIDAD K GARDINER IF SINGER C SHELDON C FINK JS TENNIS M BAKER D BOURGEOIS K CASACELI C CLAUDE K HICKEY G NOBEL R OAKES D ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH P SOTACK J WATTS A TARIOT PN GOLBE LI MILLER P HALL WJ HERNDON R DORFLINGER E MYL D MODI M OARSLEY L YOO K ELIAHOU E SHIMOUN G COLLETTA S SIEGEL J PEDDER S DUPUIS D
Citation: K. Kieburtz et al., EFFECT OF LAZABEMIDE ON THE PROGRESSION OF DISABILITY IN EARLY PARKINSONS-DISEASE, Annals of neurology, 40(1), 1996, pp. 99-107
IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA
Authors: SHOULSON I FAHN S OAKES D LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K BAKER D CASACELI C EBERLY S MCDERMOTT M NOBEL R ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH H SOTACK J WATTS A
Citation: I. Shoulson et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 29-36
IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP PATIENTS REQUIRING LEVODOPA
Authors: PENNEY JB OAKES D SHOULSON I FAHN S LANG A LANGSTON JW LEWITT P OLANOW CW TANNER C KIEBURTZ K
Citation: Jb. Penney et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP PATIENTS REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 37-45
MOVEMENT-DISORDERS INDUCED BY SYSTEMIC NOCARDIA-ASTEROIDES INOCULATION
Authors: BEAMAN B LEWITT P DEMAGGIO A SANDERS T DOMINO E
Citation: B. Beaman et al., MOVEMENT-DISORDERS INDUCED BY SYSTEMIC NOCARDIA-ASTEROIDES INOCULATION, Neurology, 46(2), 1996, pp. 6051-6051
TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS
Authors: KURTH MC ADLER CH STHILAIRE M SINGER C WATERS C CHERNIK DA DORFLINGER E YOO K DAVIS T HOEHN M LEWITT P MONTGOMERY E MUENTER M TANNER C TRUGMAN J
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS, Neurology, 45(4), 1995, pp. 275-276
A QUANTITATIVE-ANALYSIS OF ISOFERRITINS IN SELECT REGIONS OF AGED, PARKINSONIAN, AND, ALZHEIMERS DISEASED BRAINS
Authors: CONNOR JR SNYDER BS AROSIO P LOEFFLER DA LEWITT P
Citation: Jr. Connor et al., A QUANTITATIVE-ANALYSIS OF ISOFERRITINS IN SELECT REGIONS OF AGED, PARKINSONIAN, AND, ALZHEIMERS DISEASED BRAINS, Journal of neurochemistry, 65(2), 1995, pp. 717-724
CEREBROSPINAL-FLUID HOMOVANILLIC-ACID IN THE DATATOP STUDY ON PARKINSONS-DISEASE
Authors: SHOULSON I FAHN S OAKES D ODOROFF C LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K RUDOLPH A PELUSIO RM KOLLER W OLANOW W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K BRIN MF BRESSMAN SB WEINER MJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K
Citation: I. Shoulson et al., CEREBROSPINAL-FLUID HOMOVANILLIC-ACID IN THE DATATOP STUDY ON PARKINSONS-DISEASE, Archives of neurology, 52(3), 1995, pp. 237-245
A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE
Authors: KIEBURTZ K MCDERMOTT M SHOULSON I OAKES D FAHN S LANG A PENNEY JB RODNITZKY R SHULTS C TANNER C TETRUD J GORDON M LEWITT P BENNETT J KOLLER W FRIEDMAN JH KURLAN R OBRIEN C MARK MH WEINER WJ SANCHEZRAMOS J PAULSON G COMELLA C JANKOVIC J OLANOW W SHANNON K LEWIS P WINFIELD L CIECIERSKI K MISTURA K LANDOW E DIETRICH S GEBHARDT AM BARTER R KENNEDY D CULLEN KA GARDINER IF BERGEN M PATTERSON V FABRIELE M SHELDON C CORNELIUS L DUDTE K THELEN JA DUNNE C GAUGER L MALAPIRA T COURVILLE K TROTTER H PELUSIO RM RUDOLPH A CASACELI C MILLER C BOETTRICH C CONNORTON J BYRNE L ORME C BORDWELL K MCMANUS J SOTACK J RANDOLPH H KAVANAUGH B BAKER D RUMFOLA L NOBEL R EBERLY S PLUMB S WATTS A GERWITZ K DARCY S EVANS P FREDERICK D DELLAPENA L SINGLETARY V TARIOT P BELL E GRIGGS RC HALL WJ HERNDON R MARSDEN CD CHASE TN COHEN G FLEISS J JACOBS L MOSS AJ MELAMED E DORFLINGER E YOO K SHIMOUN G MORAWSKY L
Citation: K. Kieburtz et al., A CONTROLLED TRIAL OF LAZABEMIDE (RO-19-6327) IN LEVODOPA-TREATED PARKINSONS-DISEASE, Archives of neurology, 51(4), 1994, pp. 342-347
MONOAMINERGIC METABOLISM, SUBSTANCE-P, MET-ENKEPHALIN, AND BIOPTERIN IN PARKINSONS-DISEASE
Authors: LEWITT P BANNON M GALLOWAY M KAPATOS G MATSON W MCDERMOTT M OAKES D
Citation: P. Lewitt et al., MONOAMINERGIC METABOLISM, SUBSTANCE-P, MET-ENKEPHALIN, AND BIOPTERIN IN PARKINSONS-DISEASE, Neurology, 43(4), 1993, pp. 408-408
DEFINITIONS AND CLASSIFICATION OF TIC DISORDERS
Authors: FAHN S BRUUN RD CAINE E COHEN DJ COMINGS DE COMO PG CONNEALLY PM GANCHER ST GOETZ C GOLDEN GS JANKOVIC J KURLAN R LEWITT P PAULS D RIDDLE MA SHAPIRO AK SINGER HS
Citation: S. Fahn et al., DEFINITIONS AND CLASSIFICATION OF TIC DISORDERS, Archives of neurology, 50(10), 1993, pp. 1013-1016
Risultati: 1-18 |